ACAD
Acadia Pharmaceuticals Inc. · Healthcare
Principal Accounting Officer James Kihara sold $48K of Acadia Pharmaceuticals Inc.
Sold$48,300
$24.15Price
2,000Shares
−18%Stake
What ACAD did after the filing
- The stock from Tue, Jun 20 open, $23.86
- +22.4%
- S&P 500, same days
- +2.9%
Measured over 30 trading days, to the Aug 2 close.
Traded Thu, Jun 15. Filed Fri, Jun 16, 4:38 PM ET, after the close. Returns use the Jun 20 open and the Aug 2 close. Not investment advice.